Open letter to NIH for revisions to CCP recommendations

Please allow convalescent plasma as a COVID 19 treatment for immunocompromised patient like myself.

President and Karches Professor Feinstein Institute at Northwell Health

Director, Section of Transfusion Medicine and Therapeutic Pathology Department of Pathology University of New Mexico Albuquerque, NM, USA

Noreen A Hynes, M.D., M.P.H., D.T.M.H., Associate Professor of Medicine and Public Health Johns Hopkins University Schools of Medicine & Public Health Baltimore, Maryland USA

Moises A. Huaman, MD MSc Associate Professor of Medicine University of Cincinnati

Clinical Associate Professor Stanford University, School of Medicine, Dept of Pathology

Edward Cachay, MD, MAS Professor of Medicine University of California, San Diego Division of Infectious Diseases and Global Public Health

Director, Institute for Clinical and Translational Research, Baylor College of Medicine

W. Charles Huskins, M.D., M.Sc. Professor of Pediatrics Mayo Clinic College of Medicine and Science

Very important!

Well designed and executed study; not likely to be reproduced.

Based on first hand participation in this research as well as witness to the results obtained, I support revisions to current guidelines and ask that the NIH Research Committee strongly consider our request. Thank You, Dr Patrick Broderick

100% this open letter based on clinical research, the data and outcomes.